Fig. 2From: Changes in hepatitis B virus surface antibody titer and risk of hepatitis B reactivation in HBsAg-negative/HBcAb-positive patients undergoing biologic therapy for rheumatic diseases: a prospective cohort studyDifferent trends of hepatitis B virus surface antibody (HBsAb) titer associated with hepatitis B virus (HBV) DNA load. a Persistently HBsAb negative and HBV DNA detected periodically, without reactivation. b Persistently HBsAb negative, with HBV DNA detection followed by HBV reactivation. c Persistently low and HBV DNA detected periodically, without reactivation. d HBsAb titer changed from low to negative, followed by detectable HBV DNA, even HBV reactivationBack to article page